The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Xerostomia
Abstract
Xerostomia is most commonly observed in patients treated with certain medications, those subjected to radiotherapy of the head and neck, or in individuals with Sjogren's syndrome. Although it mostly affects geriatric patients, xerostomia can be also observed in young individuals. This condition not only results from the physiological process of aging but is also associated with the number and type of medications administered in the treatment of various systemic conditions. Xerostomia is also a common manifestation in menopausal women due to estrogen deficiency. If it remains untreated, xerostomia can lead to nutritional deficiencies, decreased mood, and finally, depression. Treatment is long-term and requires a high level of patient motivation. Although no standard treatment guidelines are available, many treatment options exist: topical agents to alleviate and/or prevent xerostomia, systemic therapy, or newer devices. While systemic agents (pilocarpine or cevimeline) have been largely studied, new medical devices require large well-designed clinical trials.
Related Content
|
Kamal Smimih, Bilal El-Mansoury, Chaima Azzouhri, Youssef Ait Hamdan, Fatima Ez-zahraa Saad, Merzouki Mohamed.
© 2024.
19 pages.
|
|
Fatima Ez-Zahraa Saad, Kamal Smimih, Abdelali Bitar, Manal Khanouchi.
© 2024.
12 pages.
|
|
Samira Boulbaroud, Hanane Khalki, Fatima Zahra Azzaoui.
© 2024.
28 pages.
|
|
Bilal El-Mansoury, Kamal Smimih, Youssef Ait Hamdan, Ahmed Draoui, Samira Boulbaroud, Arumugam Radhakrishnan Jayakumar.
© 2024.
23 pages.
|
|
Kamal Smimih, Chaima Azzouhri, Fatima Ez-Zahraa Saad, Youssef Ait Hamdan, Jawad Laadraoui, Nadia Zouhairi, Mohamed Merzouki.
© 2024.
17 pages.
|
|
Himel Mondal, Shaikat Mondal.
© 2024.
20 pages.
|
|
Hafida El Ghachi, Asmaa Haj-khlifa, Mjid Oukhrib, Lahcen Tamegart, Youssef Ait Hamdan, Abdelali Ben Maloui, Najib Kissani, Halima Gamrani.
© 2024.
25 pages.
|
|
|